title: [A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial].
authors.forename: A
authors.initials: A
authors.lastname: Depierre
authors.forename: C
authors.initials: C
authors.lastname: Chastang
authors.forename: B
authors.initials: B
authors.lastname: Lebeau
authors.forename: J
authors.initials: J
authors.lastname: Clavier
authors.forename: B
authors.initials: B
authors.lastname: Milleron
authors.forename: C
authors.initials: C
authors.lastname: Brambilla
authors.forename: E
authors.initials: E
authors.lastname: Quoix
authors.forename: E
authors.initials: E
authors.lastname: Lemarié
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy* / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Une nécessité: évaluer la chimiothérapie néoadjuvante des cancers bronchiques par un essai randomisé.